FDA OKs Neoadjuvant/Adjuvant Pembrolizumab in NSCLC
The US Meals and Drug Administration (FDA) has approved pembrolizumab (Keytruda) alongside platinum-containing chemotherapy as neoadjuvant therapy and continued as...
OKs
The US Meals and Drug Administration (FDA) has approved pembrolizumab (Keytruda) alongside platinum-containing chemotherapy as neoadjuvant therapy and continued as...
